摘要
通过解读美国食品药品监督管理局"确保上市医疗器械的安全性:器械和放射健康中心(CDRH)医疗器械上市后安全性监测计划"的工作报告,了解其开展上市后监测工作框架、流程及特点,以期对我国的医疗器械上市后监测工作体系的建立和完善有所启示。
After reviewing the FDA's report of medical device post-market something about the Structure and procedures of FDA in this area. Aims safety program, We know to give some apocalypse about the medical device post-market safety program for our country.
出处
《中国药物警戒》
2009年第4期244-246,共3页
Chinese Journal of Pharmacovigilance
关键词
美国
医疗器械上市后监测
框架
特点
FDA
medical device post-market safety program
framework
characteristics